EUVIMEDEUVIMED entdecken
Crossref

Do haematological parameters such as HALP and Lymphocyte to C-reactive protein ratio predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer?

Mevlüt Yordanagil, Hüseyin Bakir, Gülhan Güler Avci, Murat Yildirim, Namik Ozkan, Okan Ismail

Polish Journal of Surgery · 18.11.2022 · 95 (3) · 21-29

DOI: 10.5604/01.3001.0016.0959 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Journal of Surgery, erschienen am 18.11.2022. Verfasst von Mevlüt Yordanagil und 5 weiteren Autor:innen. Beteiligte Einrichtung: Gaziosmanpasa University Medical Facuty Hospital, General Surgery Department. Turkey. Hauptthemen laut MEDLINE: C-Reactive Protein, Rectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Inflammatory markers are effective in determining the prognosis of malignant diseases. The aim of this study is to investigate the relationship of HALP and LCR with tumor response after neoadjuvant chemoradiotherapy and their effects on prognosis in patients with locally advanced rectal cancer.

Methods

Eighty-eight patients who received nCRT with the diagnosis of LARC were included in the study. First, all patients were divided into 2 groups: patients with pathological and clinical complete response (pCR+cCR), group 1, and patients with non-complete response, group 2. The 82 patients who underwent surgery were divided into two groups according to the TRG Dworak: good response and poor response groups. Inflammation markers such as HALP and LCR were obtained using biochemical parameters.

Results

HALP and LCR were higher in the complete response group than in the none-complete response group (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinRectal NeoplasmsHumansNeoadjuvant TherapyInflammationLymphocytes

Stichwörter der Autor:innen

Locally advanced rectal cancerLocally advanced rectal cancer; neoadjuvant chemoradiotherapy; tumor response;…neoadjuvant chemoradiotherapytumor response inflammatory markers.

Substanzen

C-Reactive Protein

Autor:innen und Institutionen

  • Gaziosmanpasa University Medical Facuty Hospital, General Surgery Department. Turkey.
  • Gaziosmanpasa University Medical Faculty Hospital, General Surgery Department. Tokat. Turkey.
  • Gaziosmanpasa University Medical Faculty Hospital, Radiation Oncology Department. Tokat. Turkey.

Zitieren

APA

Yordanagil, M., Bakir, H., Güler Avci, G., Yildirim, M., Ozkan, N., & Ismail, O. (2022). Do haematological parameters such as HALP and Lymphocyte to C-reactive protein ratio predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer?. Polish Journal of Surgery, 95(3), 21-29. https://doi.org/10.5604/01.3001.0016.0959

Vancouver

Yordanagil M, Bakir H, Güler Avci G, Yildirim M, Ozkan N, Ismail O. Do haematological parameters such as HALP and Lymphocyte to C-reactive protein ratio predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer?. Polish Journal of Surgery. 2022;95(3):21-29. doi:10.5604/01.3001.0016.0959

BibTeX
@article{Yordanagil2022,
  author = {Yordanagil, Mevlüt and Bakir, Hüseyin and Güler Avci, Gülhan and Yildirim, Murat and Ozkan, Namik and Ismail, Okan},
  title = {Do haematological parameters such as HALP and Lymphocyte to C-reactive protein ratio predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer?},
  journal = {Polish Journal of Surgery},
  year = {2022},
  volume = {95},
  number = {3},
  pages = {21--29},
  doi = {10.5604/01.3001.0016.0959}
}
Kostenlos starten →